Jaschke W, Hoevels J
Institut für Klinische Radiologie, Fakultät für Klinische Medizin, Universität Heidelberg, Mannheim, West Germany.
Acta Radiol. 1988 Jan-Feb;29(1):15-9.
Two patients with abdominal hemorrhage from a hepatic tumor underwent transcatheter embolization using Ethibloc. The hemorrhage ceased rapidly in both patients. No complications related to the embolization procedure were observed. One patient is doing well after 4 years. The second patient died of extensive metastatic disease eleven weeks after embolization. Control angiography after 14 months and 2 weeks, respectively, demonstrated persistent occlusion of the embolized hepatic arteries. Ethibloc offers the advantage of permanent vascular occlusion and appears to be a safe and effective embolization material for partial occlusion of the hepatic arteries.
两名患有肝肿瘤导致腹腔出血的患者接受了使用Ethibloc的经导管栓塞术。两名患者的出血均迅速停止。未观察到与栓塞手术相关的并发症。一名患者在4年后情况良好。第二名患者在栓塞术后11周死于广泛转移性疾病。分别在14个月和2周后进行的对照血管造影显示,栓塞的肝动脉持续闭塞。Ethibloc具有永久性血管闭塞的优势,似乎是一种用于部分闭塞肝动脉的安全有效的栓塞材料。